v3.26.1
Fair Value (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets And Liabilities Measured at Fair Value On Recurring Basis

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):

 

 

 

June 30, 2026

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

76

 

 

$

 

 

$

 

 

$

76

 

Commercial paper

 

 

 

 

 

22,982

 

 

 

 

 

 

22,982

 

Total cash equivalents

 

 

76

 

 

 

22,982

 

 

 

 

 

 

23,058

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

 

 

 

4,675

 

 

 

 

 

 

4,675

 

U.S. government debt and agency
   securities

 

 

 

 

 

14,069

 

 

 

 

 

 

14,069

 

Total short-term investments

 

$

 

 

 

18,744

 

 

$

 

 

$

18,744

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets subject to fair value
   measurements on a recurring basis

 

$

76

 

 

$

41,726

 

 

$

 

 

$

41,802

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Milestone liability

 

 

 

 

 

 

 

 

14,362

 

 

 

14,362

 

Total liabilities subject to fair value
   measurements on a recurring basis

 

$

 

 

$

 

 

$

14,362

 

 

$

14,362

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2025

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

17,299

 

 

$

 

 

$

 

 

$

17,299

 

U.S. government debt and agency
   securities

 

 

 

 

 

2,541

 

 

 

 

 

 

2,541

 

Commercial paper

 

 

 

 

 

32,314

 

 

 

 

 

 

32,314

 

Total cash equivalents

 

 

17,299

 

 

 

34,855

 

 

 

 

 

 

52,154

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

 

 

 

5,209

 

 

 

 

 

 

5,209

 

U.S. government debt and agency
   securities

 

 

 

 

 

13,846

 

 

 

 

 

 

13,846

 

Total short-term investments

 

 

 

 

 

19,055

 

 

 

 

 

 

19,055

 

Total assets subject to fair value
   measurements on a recurring basis

 

$

17,299

 

 

$

53,910

 

 

$

 

 

$

71,209

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Sermonix pre-funded warrant

 

$

 

 

$

 

 

$

37,488

 

 

 

37,488

 

Milestone liability

 

 

 

 

 

 

 

 

15,116

 

 

 

15,116

 

Total liabilities subject to fair value
   measurements on a recurring basis

 

$

 

 

$

 

 

$

52,604

 

 

$

52,604

 

Schedule of Fair Value Sermonix Pre-funded Warrant And Milestone Liability At Issuance

The key inputs into the fair value of the Sermonix Pre-Funded Warrant at December 31, 2025 were as follows:

 

 

 

Sermonix Pre-Funded Warrant

 

 

 

 

 

December 31, 2025

 

Fair Value of Common Stock

 

 

 

$

7.57

 

Volatility

 

 

 

 

97.0

%

Risk-free rate

 

 

 

 

3.7

%

Dividend Yield

 

 

 

 

0.0

%

Holding period years

 

 

 

 

0.20

 

The key inputs into the fair value of the Milestone Liability at December 31, 2025 and at June 30, 2026 were as follows:

 

 

 

Milestone Liability

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Weighted Average Cost of Capital

 

 

11.0

%

 

 

11.0

%

Probability

 

 

43.9

%

 

 

43.9

%

Schedule of Changes in Fair Value Sermonix Pre-funded Warrant And Milestone Liability

Below is a summary of the change in fair value of the Sermonix Pre-Funded Warrant and the Milestone Liability from December 31, 2025 to June 30, 2026:

 

 

 

Sermonix
Pre-Funded
Warrant

 

 

Milestone
Liability

 

December 31, 2025

 

$

37,488

 

 

$

15,116

 

Change in fair value

 

 

16,320

 

 

 

(929

)

Reclassified to equity

 

 

(53,808

)

 

 

 

March 31, 2026

 

$

 

 

$

14,187

 

Change in fair value

 

 

 

 

 

175

 

June 30, 2026

 

$

 

 

$

14,362

 

Schedule of Fair Value of Cash Equivalents and Short-term Investments

The following tables reflect the Company’s financial asset balances measured at fair value on a recurring basis (in thousands):

 

 

 

June 30, 2026

 

 

 

Level

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

1

 

$

76

 

 

$

 

 

$

 

 

$

76

 

Commercial paper

 

2

 

 

22,985

 

 

 

 

 

 

(3

)

 

 

22,982

 

Total cash equivalents

 

 

 

$

23,061

 

 

$

 

 

$

(3

)

 

$

23,058

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

2

 

 

4,676

 

 

 

 

 

 

(1

)

 

 

4,675

 

U.S. government debt and agency
   securities

 

2

 

 

14,074

 

 

 

 

 

 

(5

)

 

 

14,069

 

Total short-term investments

 

 

 

$

18,750

 

 

$

 

 

$

(6

)

 

$

18,744

 

 

 

 

December 31, 2025

 

 

 

Level

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

1

 

$

17,299

 

 

$

 

 

$

 

 

$

17,299

 

U.S. government debt and agency
   securities

 

2

 

 

2,541

 

 

 

 

 

 

 

 

 

2,541

 

Commercial paper

 

2

 

 

32,319

 

 

 

 

 

 

(5

)

 

 

32,314

 

Total cash equivalents

 

 

 

$

52,159

 

 

$

 

 

$

(5

)

 

$

52,154

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

2

 

 

5,210

 

 

 

 

 

 

(1

)

 

 

5,209

 

U.S. government debt and agency
   securities

 

2

 

 

13,844

 

 

 

2

 

 

 

 

 

 

13,846

 

Total short-term investments

 

 

 

$

19,054

 

 

$

2

 

 

$

(1

)

 

$

19,055